Oaktree Acquisition Corp. III Life Sciences (OACCU) Equity Average (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACCU) reported Equity Average of -$7.0 million for Q1 2026, down 11.14% on a YoY basis from -$7.9 million in Q1 2025, and down 3.41% quarter-over-quarter from -$6.8 million in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACCU) Equity Average (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Equity Average for 2 years, with the latest figure at -$7.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Equity Average fell 11.14% year-over-year to -$7.0 million; the trailing twelve-month figure through Mar 2026 stood at -$7.0 million (down 11.14% YoY), and the FY2025 full-year result was -$6.4 million, changed N/A from the prior year.
  • Equity Average for Q1 2026 stood at -$7.0 million, down from -$6.8 million in the prior quarter.
  • The five-year high for Equity Average was -$6.3 million in Q1 2025, with the low at -$7.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -16.34 Mn
2 Berto Acquisition 312.16 Mn 312.16 Mn - -11.95 Mn
3 Centurion Acquisition 311.79 Mn 311.79 Mn - -13.69 Mn
4 Churchill Capital Corp IX 309.64 Mn 309.64 Mn - -10.65 Mn
5 WEN Acquisition 308.55 Mn 308.55 Mn - -13.60 Mn
6 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - -28.22 Mn
7 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - -8.00 Mn
8 Soulpower Acquisition 265.17 Mn 265.17 Mn - -11.12 Mn
9 BTC Development 263.21 Mn 263.21 Mn - -8.88 Mn
10 Oaktree Acquisition Corp. III Life Sciences - - - -7.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.00 Mn
Dec 31, 2025 -6.77 Mn
Sep 30, 2025 -6.65 Mn
Jun 30, 2025 -6.53 Mn
Mar 31, 2025 -6.30 Mn